Literature DB >> 809966

Proliferation of ineffective erythropoiesis with nuclear abnormalities and megaloblastoid appearance in preleukaemia.

P S Mitrou, M Fischer, K Hübner.   

Abstract

Erythropoiesis of two patients in the early stage of acute leukaemia and two patients with refractory anaemia and hypercellular bone marrow (preleukaemia?) was studied with the cytophotometric-autoradiographic method. Megaloblastoid erythroblasts show a decreased proliferative activity in comparison to the morphologically normal cells and are in the maturation stage of E4 (early polychromatic normoblasts) mainly in the G1-phase; they are therefore largely comparable to the megaloblastoid erythroblasts in erythroleukaemia. Erythroblasts in preleukaemia with nuclear abnormalities are found in a high percentage in the G2-phase or are unlabelled with a DNA content of between diploid and tetraploid value. They show a similar proliferative behaviour to the megaloblasts in pernicious anaemia. Early polychromatic erythroblasts arrested in G2-phase can differentiate without mitosis into tetraploid mature erythroblasts (E5). They can divide elsewhere endomitotically, produce binucleated E5 or take up the DNA synthesis and become polyploid. E4 with nuclear abnormalities do not proliferate and are mainly found in the premitotic phase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809966     DOI: 10.1159/000208085

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  2 in total

1.  Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.

Authors:  Varvara Trachana; Karel H M van Wely; Astrid Alonso Guerrero; Agnes Fütterer; Carlos Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

2.  [A prospective study on course and prognostic criteria in "preleukemia" (author's transl)].

Authors:  H Heimpel; P Drings; P Mitrou; W Queisser
Journal:  Klin Wochenschr       Date:  1979-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.